{"count": 1, "results": [{"_id": "25154151", "pmid": 25154151, "title": "A multicentric double blind randomised controlled trial of atenolol versus losartan as first line drug for mild to moderate essential hypertension.", "journal": "J Indian Med Assoc", "authors": ["Guha S", "Avasthi R", "Narain VS", "Rajendiran C", "Mitra M", "Ray S", "Majumdar D", "Mondal MM", "Mani S", "Mookerjee S", "Saha J", "Dastidaro DG"], "date": "2013-12-01T00:00:00Z", "meta_date_publication": "2013 Dec", "meta_volume": "111", "meta_issue": "12", "meta_pages": "821-5", "score": 50067.234, "text_hl": "The dose of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ or @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ was 50 mg once daily at 8 am in the @<m>DISEASE_Morning_Sickness</m> @DISEASE_MESH:D048968 @@@morning@@@. ", "citations": {"NLM": "Guha S, Avasthi R, Narain VS, Rajendiran C, Mitra M, Ray S, Majumdar D, Mondal MM, Mani S, Mookerjee S, Saha J, Dastidaro DG. A multicentric double blind randomised controlled trial of atenolol versus losartan as first line drug for mild to moderate essential hypertension. J Indian Med Assoc. 2013 Dec;111(12):821-5. PMID: 25154151", "BibTeX": "@article{25154151, title={A multicentric double blind randomised controlled trial of atenolol versus losartan as first line drug for mild to moderate essential hypertension.}, author={Guha S and Avasthi R and Narain VS and Rajendiran C and Mitra M and Ray S and Majumdar D and Mondal MM and Mani S and Mookerjee S and Saha J and Dastidaro DG}, journal={J Indian Med Assoc}, volume={111}, number={12}, pages={821-5}}"}}]}